Pulmonary hypertension MRI

Revision as of 18:50, 12 September 2011 by Ralph Matar (talk | contribs) (New page: {{Pulmonary hypertension}} {{CMG}}, Richard Channick, M.D.; '''Assistant Editor(s)-in-Chief:''' Ralph Matar, Lisa Prior, [[Ann Slater|Ann Slater, R...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension MRI

CDC on Pulmonary hypertension MRI

Pulmonary hypertension MRI in the news

Blogs on Pulmonary hypertension MRI

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Richard Channick, M.D.; Assistant Editor(s)-in-Chief: Ralph Matar, Lisa Prior, Ann Slater, R.N.

Cardiac MR

Due to the important prognostic indicators of the function of the right ventricle in patients with PAH. Cardiac MR is performed in some patients to accurately evaluate the size, morphology and function of the right ventricle.

It is also used for follow-up of right heart hemodynamics for follow-up purposes.

Poor right ventricular function is indicated by the following according to the ACCF/AHA 2009 Expert consensus document on pulmonary hypertension:

  1. Stroke volume ≤25ml/m^2.
  2. Right ventricular end-diastolic volume ≥84ml/m^2( Most appropriate marker of right ventricular failure in the follow-up.)
  3. Left ventricvular end-diastolic volume ≤40ml/m^2



Pulmonary artery stiffness measured by relative cross sectional area change ≤16% also has implications on mortality rate.